ALERE ORATECT ORATECT III HM12-CE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign report with the FDA on 2018-10-02 for ALERE ORATECT ORATECT III HM12-CE manufactured by Ameditech, Inc..

Event Text Entries

[122451465] This event occurred in (b)(6) with a product of identical manufacturing to a us marketed product. Ameditech made the decision to report this event to the agency based on the similarity between the product involved in this event and the oratect iii, catalog numebr hm12, product marketed for in vitro diagnostic use in the united states. Device similarities include the detection analytes used to obtain test results, and identical sample collection pads, with the major diference being the ce marked labeling for the devices sold in (b)(6). The sample collection pad is the point of contact between the device and the patient, and is the likely component to which the patient may have experienced allergic symptoms. Kligman maximization testing was performed on this collection pad in 2014. This testing categorized the collection pad with a grade 1 sensitization rate, the lowest available allergic potential score. Thus the risk of allergic reaction has been reduced as far as possible. A historical review was conducted and determined that this is the first allergic reaction reported for the catalog number, and the second report for the oratect product family since distribution of the product began in 2012, thereby indicating a low frequency of occurrence. Further investigation is ongoing.
Patient Sequence No: 1, Text Type: N, H10


[122451466] On (b)(6) 2018 a test sample for drug screening on an oratect iii device, catalog number hm12-ce was collected from a patient. After providing the sample the donor informed the testing technician that he was experiencing some irritation and blistering on the inside of his cheek, indicating a possible allergic reaction to the oratect device. The patient was monitored for several minutes and the testing staff noted that no further symptoms occurred. The patient was then released, and did not seek further medical attention. Repeated attempts to gather lot number information from the customer were made on (b)(6), 11th, 12th, 13th, 19th, 20th, and 24th, however the customer was unable to confirm the lot of product involved in the event.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2032598-2018-00001
MDR Report Key7928072
Report SourceFOREIGN
Date Received2018-10-02
Date of Report2018-09-07
Date of Event2018-09-07
Date Mfgr Received2018-09-07
Date Added to Maude2018-10-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. ANGELA OCCHIONERO
Manufacturer Street9940 MESA RIM ROAD
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8585351968
Manufacturer G1AMEDITECH, INC.
Manufacturer Street9940 MESA RIM ROAD
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal Code92121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameALERE ORATECT
Generic NameORATECT ORAL FLUID DRUG SCREEN DEVICE
Product CodeDJC
Date Received2018-10-02
Model NumberORATECT III
Catalog NumberHM12-CE
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerAMEDITECH, INC.
Manufacturer Address9940 MESA RIM ROAD SAN DIEGO CA 92121 US 92121


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-10-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.